Previous close | 0.8800 |
Open | 0.8800 |
Bid | 0.8700 x N/A |
Ask | 0.8800 x N/A |
Day's range | 0.8600 - 0.8800 |
52-week range | 0.8100 - 2.3200 |
Volume | |
Avg. volume | 373,654 |
Market cap | 269.917M |
Beta (5Y monthly) | 1.39 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
With fears of economic turbulence receding, Aurora Cannabis, Canopy Growth, and Organigram rebounded from their Monday declines.
Investors in cannabis companies should know they're playing a long game. The multi-state operator (MSO) has seen its shares drop 35% over the past year, and that fall has continued with a 9% decline so far in 2023.
It can be hard for investors to see anything good in the cannabis space through all the smoke of 2022's collapsing share prices. Thanks to the market's general malaise regarding the industry, at least three are selling at discounts and look likely to be great long-term holdings over the next decade: Trulieve Cannabis (OTC: TCNNF), NewLake Capital Partners (OTC: NLCP) and OrganiGram Holdings (NASDAQ: OGI). All three cannabis companies are trading at price-to-book ratios below what their assets would bring if sold off, and at lower ratios than other large cannabis companies such as Canopy Growth and Curaleaf Holdings.